STK11 inactivation leads to the an increased infiltrate of protumoral neutrophils, a decrease of tumor-infiltrating cells and reduced PD1 and PD-L1 expressions in the tumor microenvironment, both in a KRAS-driven mouse model of lung adenocarcinoma and in cell lines [15]. Here, KRAS is linked to neoplasm.